Perioperative Pain Management for Total Shoulder Arthroplasty: A Pilot Non-Inferiority Trial
Shoulder Arthritis, Anesthesia, Local, Local Infiltration
About this trial
This is an interventional treatment trial for Shoulder Arthritis
Eligibility Criteria
Inclusion Criteria: Patients undergoing total shoulder arthroplasty for: Osteoarthritis Rheumatoid arthritis Rotator cuff arthropathy Acute fracture Fracture sequelae. Exclusion Criteria: Patients with known allergy to study medications Patients with obstructive sleep apnea Prior TSA patients previously on chronic narcotic medication patients who are unable to read English patients not able/willing to follow up for the study period of 12 months.
Sites / Locations
- St. Josephs Healthcare London
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Regional Brachial Plexus Blockade
Local Infiltration Anesthesia
Ultrasound guided brachial plexus blocade with 10 ml of 0.5% ropivacaine using a high frequency linear array transducer.
High volume local infiltration anesthesia with 100 mL of 0.9% normal saline (57ml), 0.5% ropivacaine (40 ml), 10 mg morphine (10 mg/ml), 0.1 mg of epinephrine (0.1 mg/ml), and 30 mg of ketorolac (30 mg/ml) divided equally into a 20 ml five-zone field infiltration into the suprascapular notch/posterior capsule (suprascapular and axillary nerves), coracobrachialis muscle, anterior deltoid muscle, superior pectoralis major muscle, and skin incision at the conclusion of the procedure by the treating surgeon.